CORTI, GIAMPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.813
EU - Europa 14.678
AS - Asia 6.030
SA - Sud America 826
OC - Oceania 171
AF - Africa 165
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 36.688
Nazione #
US - Stati Uniti d'America 14.640
PL - Polonia 5.097
RU - Federazione Russa 3.214
IT - Italia 2.028
SG - Singapore 1.604
HK - Hong Kong 1.097
CN - Cina 1.078
UA - Ucraina 942
IE - Irlanda 867
VN - Vietnam 779
DE - Germania 702
SE - Svezia 675
BR - Brasile 672
KR - Corea 637
FI - Finlandia 389
FR - Francia 375
IN - India 225
GB - Regno Unito 206
AU - Australia 168
CA - Canada 109
JP - Giappone 98
BD - Bangladesh 79
ID - Indonesia 74
JO - Giordania 56
AR - Argentina 54
TR - Turchia 54
SC - Seychelles 46
IQ - Iraq 45
NL - Olanda 39
MX - Messico 32
ZA - Sudafrica 29
AE - Emirati Arabi Uniti 23
CO - Colombia 23
ES - Italia 21
PK - Pakistan 21
TH - Thailandia 20
EC - Ecuador 19
BE - Belgio 18
BG - Bulgaria 17
CI - Costa d'Avorio 16
CL - Cile 15
MA - Marocco 14
MY - Malesia 14
NG - Nigeria 14
PY - Paraguay 14
RO - Romania 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
IL - Israele 13
EG - Egitto 12
NP - Nepal 12
PH - Filippine 12
AT - Austria 10
DZ - Algeria 10
PT - Portogallo 10
CH - Svizzera 9
CZ - Repubblica Ceca 9
KE - Kenya 9
PE - Perù 9
VE - Venezuela 9
AZ - Azerbaigian 8
KZ - Kazakistan 8
DO - Repubblica Dominicana 7
BO - Bolivia 6
GR - Grecia 6
OM - Oman 6
TN - Tunisia 6
DK - Danimarca 5
JM - Giamaica 5
LB - Libano 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
BH - Bahrain 4
CR - Costa Rica 4
KG - Kirghizistan 4
LT - Lituania 4
QA - Qatar 4
UY - Uruguay 4
EE - Estonia 3
EU - Europa 3
GE - Georgia 3
IR - Iran 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SY - Repubblica araba siriana 3
BY - Bielorussia 2
ET - Etiopia 2
GH - Ghana 2
HN - Honduras 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
AM - Armenia 1
AQ - Antartide 1
AW - Aruba 1
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
GA - Gabon 1
Totale 36.667
Città #
Warsaw 5.093
Santa Clara 3.027
Jacksonville 1.406
Singapore 1.018
Chandler 929
Dublin 867
Hong Kong 850
Ashburn 843
Fairfield 743
Seoul 615
Wilmington 384
Cambridge 358
San Jose 356
Woodbridge 330
Los Angeles 324
Houston 305
Beijing 291
The Dalles 290
Princeton 288
Seattle 265
Boardman 263
Buffalo 262
Lauterbourg 235
Boston 212
Hanoi 192
New York 190
Ho Chi Minh City 187
Ann Arbor 162
Melbourne 154
Mumbai 154
Hefei 151
Milan 139
Moscow 139
Medford 136
Dallas 135
Florence 133
Council Bluffs 120
Rome 106
Helsinki 103
Tokyo 90
Dong Ket 85
Altamura 80
Munich 78
Lawrence 75
São Paulo 64
Norwalk 60
Auburn Hills 56
Toronto 53
Frankfurt Am Main 52
San Diego 52
Kent 51
Jakarta 49
Hillsboro 46
Verona 45
Shanghai 41
Orem 39
Haiphong 38
Naples 38
Andover 36
Phoenix 31
Da Nang 30
Denver 29
Rio de Janeiro 29
Bologna 27
Chicago 27
Belo Horizonte 26
Frankfurt am Main 26
Atlanta 25
Redondo Beach 25
Turku 24
Bremen 23
Clifton 23
Brooklyn 22
Guangzhou 22
Izmir 21
Montreal 21
Paris 21
San Francisco 21
Dearborn 20
London 20
Abidjan 16
Baghdad 16
Yubileyny 16
Bangkok 15
Brussels 15
Sofia 15
Turin 15
Falls Church 14
Brasília 13
Johannesburg 13
San Mateo 13
Seongnam 13
Sydney 13
Tashkent 13
Abuja 12
Austin 11
Dhaka 11
Hải Dương 11
Redwood City 11
Manchester 10
Totale 23.662
Nome #
Nuove prospettive terapeutiche: fra presente e futuro 924
Meningite da virus Toscana 806
Fibrosi cistica e terapia antibiotica. Odi et amo 669
Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics 401
Osteomielite sternale da Staphylococcus aureus meticillino-resistente (MRSA) e Corynebacterium striatum complicata da endocardite mitralica: nuovo approccio terapeutico con daptomicina 374
Evaluation of the prognostic value of liver stiffness in patients with hepatitis C virus treated with triple or dual antiviral therapy: A prospective pilot study 313
Antibiotic resistance in community-acquired pulmonary pathogens 303
Is Streptococcus pneumoniae a nosocomially acquired pathogen? 294
Skeletal tuberculosis and other granulomatous infections 288
Effect of antibiotic pretreatment on resistance 285
Late diagnosis of histoplasmosis in a Brazilian patient with acquired immunodeficiency syndrome 285
Antimicrobial resistance in an intensive care unit before adopting an antibiotic rotation programme for empiric therapy of ventilator-associated pneumonia 284
Which prophylactic regimen for which surgical procedure? 280
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains 279
Acute hepatitis C and nosocomial transmission of hepatitis C virus: an emergent threat in the hospital setting? 278
Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period 275
Approccio terapeutico all’epatite da virus delta (HDV) in tre diversi casi 270
Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections 267
Atassia cerebellare acuta in corso di mononucleosi infettiva 264
Invasive Streptococcus pyogenes infection in a surgeon after an occupational exposure 264
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic 263
Late-onset rhabdomyolysis in pneumococcal meningitis: a case report 257
Infections in multiple myeloma 256
Malattie zoonotiche emergenti 256
Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients 255
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 253
Terapia antibiotica delle polmoniti nosocomiali 252
Spondilodisciti: report di 2 casi di tubercolosi (TB) con infezione disseminata 252
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia 247
Ruolo del linezolid nella terapia delle infezioni causate da cocchi gram-positivi multiresistenti 244
Toscana virus, a “Mediterranean” agent of aseptic meningitis: analysis of 42 consecutive cases 243
La terapia delle infezioni fungine invasive: dubbi e certezze 240
Nuove prospettive terapeutiche nel trattamento delle infezioni in comunità 238
Ruolo diagnostico degli ultrasuoni nella patologia venosa: casi clinici di ulcere venose 235
Terapia delle infezioni intra-addominali complicate: qualcosa è cambiato nel nostro orizzonte terapeutico? 232
Penetrazione degli antibiotici in distretti speciali 231
Pathogenetic mechanisms responsible for the production of secondary immunodeficiency 230
Acute viral hepatitis increases liver stiffness values measured by transient elastography 229
The metabolic fingerprints of HCV and HBV infections studied by Nuclear Magnetic Resonance Spectroscopy 229
Unusual Methylobacterium fujisawaense infection in a patient with acute leukaemia undergoing hematopoietic stem cell transplantation: first case report 220
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 220
Treatment of otitis media 220
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 212
Old oral antibiotics can be suitable alternatives to glycopeptides and new antimicrobial agents for therapy of skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA) 209
HepaDisk – A new quality of life questionnaire for HCV patients 204
Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period 202
Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study 199
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 197
Seroprevalence of hepatitis a virus, hepatitis e virus, and helicobacter pylori in rural communities of the Bolivian Chaco, 2013 195
Cryptic severe plasmodium falciparum malaria in a moroccan man living in Tuscany, Italy, August 2018 195
Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany 188
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 182
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region (Bolivia) 182
In vitro antibacterial activity of imipenem and other agents against Gram-negative and Gram-positive strains isolated from clinical specimens 180
Early discharge criteria in patients with acute bacterial skin and skin structure infections in a large tertiary-care teaching hospital in Florence, Italy 179
A unique HAV strain circulated in patients with acute HAV infection with different risk exposures in Tuscany, Italy 177
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 177
Epidemiology of pneumococcal resistance in Florence: much more erythromycin-nonsusceptible (ENSP) than penicillin-nonsusceptible (PNSP) strains 176
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 176
Arbo-score: A rapid score for early identification of patients with imported arbovirosis caused by Dengue, Chikungunya and zika virus 175
Trypanosoma cruzi infection in the human population of the Bolivian Chaco: Four serosurveys over a 26-year period (1987-2013) 174
Different metabolic fingerprints between HCV and HBV patients: a possible interference of the two major hepatitis viruses in basal metabolism pathways. 171
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 170
Incidence of penicillin- (PNSP) and erythromycin- (ENSP) nonsusceptible pneumococci in Florence, Italy, 1992-1999 167
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 164
Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries 160
Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report 159
Lumbar pain in a married couple who likes cheese: brucella strikes again! 158
Meropenem versus imipenem/cilastatin in the hospital treatment of community-acquired pneumonia 154
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 154
Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male 152
Early HCV-RNA clearance during daily administration of interferon in combination with ribavirin in naive HCV patients 152
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 151
Ictus acuto. 150
Hepatitis C virus infection: opportunities for an earlier detection in primary care 149
Chronic hepatitis C virus hepatitis and psoriasis: No longer a contraindication to interferon use in the era of biological agents? 149
Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011–2016 148
Very short course of triple therapy including telaprevir for chronic hepatitis C: a possible strategy in selected patients 146
Interactions between antibiotics and immune system 145
Monoterapia o terapia d’associazione in pazienti immunocompromessi con epatite cronica B? 144
Attività comparativa in vitro di meropenem, nuova molecola carbapenemica, nei confronti di batteri gram-positivi e gram-negativi 144
Cefepime 143
Severe head and neck infections in the critical care unit 142
Alternative antibiotics for methicillin-resistant (MR) staphylococcal skin lesions in at-risk patients: preliminary results of a surveillance programme in Florence, Italy 139
Resistenza a ciprofloxacin di stafilococchi coagulasi-negativi meticillino-resistenti isolati nell'area fiorentina 138
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia 138
Approccio terapeutico alle infezioni nosocomiali 137
Viral kinetics in patients with chronic hepatitis B treated with combination therapy with PEG-IFN and nucleoside analogues 137
Attività comparativa in vitro di MDL 62873 nei confronti di microrganismi gram-positivi 136
Leptospirosis acquired by tourists in Venice, Italy 136
Considerazioni farmacoeconomiche sulla terapia antibiotica delle infezioni osteo-articolari 135
Acquired immunodeficiency 134
Daily IFN and ribavirin administration induces early HCV-RNA clearance 134
Anemizzazione severa in paziente con HCV genotipo 1b trattato con triplice terapia comprendente telaprevir 133
Secondary immunodeficiency 132
Serum cytokine and chemokine changes during Toscana virus meningitis 131
Le resistenze batteriche mediate da beta-lattamasi a spettro esteso: conseguenze terapeutiche 130
Is Streptococcus pneumoniae a nosocomially-acquired pathogen? 129
Antimicrobial resistance (AR) among respiratory pathogens (RP): a unique epidemiology in Italy 128
Tolvaptan efficacy and drug-drug interactions. 126
Totale 21.929
Categoria #
all - tutte 88.817
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.817


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021461 0 0 0 0 0 0 0 0 0 0 104 357
2021/20221.484 56 247 45 84 29 40 59 79 43 53 337 412
2022/20233.814 456 279 131 305 414 874 391 229 454 50 160 71
2023/20241.468 100 194 325 132 74 146 30 254 30 43 81 59
2024/20258.836 313 1.024 537 1.354 2.547 1.221 94 379 655 234 244 234
2025/20268.523 993 1.308 556 568 887 364 1.237 574 545 549 942 0
Totale 36.804